YUNHONG GREEN CTI LTD. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that YUNHONG GREEN CTI LTD. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.59M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $3.60M | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $3.26M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $3.14M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $3.76M | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | $3.09M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $4.38M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $10.04M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $13.75M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $17.12M | Apr 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.53M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($1.50M) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | ($235.0K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($1.47M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($8.27M) | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | ($4.43M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($7.13M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($3.59M) | May 15, 2020 |
| FY2019 | Dec 31, 2017 | ($1.60M) | May 15, 2020 |
| FY2018 | Dec 31, 2016 | $700.0K | Apr 16, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.05M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($612.0K) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | ($399.0K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($1.12M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($506.0K) | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | ($1.04M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($3.12M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($642.5K) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $629.8K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $2.84M | Apr 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $200.0K | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $200.0K | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $200.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $200.0K | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $206.0K | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | $317.0K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $287.0K | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $375.0K | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $345.0K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $496.0K | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($172.0K) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($1.27M) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | ($1.22M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $2.37M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($3.71M) | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | $1.32M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $3.67M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($1.23M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $1.26M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($448.9K) | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $331.0K | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $221.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $163.0K | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $122.0K | Apr 12, 2023 |
| FY2017 | Dec 31, 2017 | $753.2K | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $630.2K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $682.0K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $1.17M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $2.06M | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $1.21M | Apr 1, 2014 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.46M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $25.58M | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $17.25M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $15.28M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $17.28M | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | $21.55M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $31.32M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $38.76M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $39.98M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $43.91M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.91M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $14.88M | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $13.52M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $12.54M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $13.23M | Apr 12, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.56M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $10.70M | Mar 23, 2026 |
| FY2025 | Dec 31, 2023 | $3.73M | Mar 23, 2026 |
| FY2024 | Dec 31, 2022 | $2.75M | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | $4.05M | Mar 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.19M | Apr 12, 2023 |
| FY2020 | Dec 31, 2019 | $1.98M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $7.33M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $11.36M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $12.72M | Apr 2, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | Apr 15, 2022 |
| FY2021 | Dec 31, 2020 | $0 | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.47M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $1.47M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $1.47M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $1.47M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $1.47M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $1.47M | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $1.03M | Apr 1, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($28.39M) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | ($25.86M) | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | ($24.36M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($24.12M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($22.66M) | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | ($14.38M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($9.99M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($2.87M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $720.2K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $2.32M | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $97.0K | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | $220.0K | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | $921.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $146.0K | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $66.0K | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | $322.2K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $845.1K | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $258.2K | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $181.0K | Apr 16, 2019 |
| FY2018 | Dec 31, 2016 | $563.0K | Apr 16, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $7.01M | Mar 29, 2024 |
| FY2023 | Dec 31, 2022 | $4.86M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $6.92M | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | $8.62M | Apr 15, 2022 |
| FY2016 | Dec 31, 2016 | $8.88M | Mar 31, 2017 |
| FY2016 | Dec 31, 2015 | $8.85M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $9.16M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $9.44M | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $7.98M | Apr 1, 2014 |
| FY2012 | Dec 31, 2011 | $4.17M | Apr 15, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | (1) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | (1) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | (1) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | (1) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.60M | Mar 23, 2026 |
| FY2025 | Dec 31, 2024 | 2.59M | Mar 23, 2026 |
| FY2024 | Dec 31, 2023 | 20.77M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 16.06M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 5.89M | Apr 12, 2023 |
| FY2021 | Dec 31, 2020 | 5.78M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 3.84M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | 3.84M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | 3.54M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 3.53M | Apr 2, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $158.4K | Mar 29, 2012 |
| FY2011 | Dec 31, 2010 | $314.4K | Mar 29, 2012 |